Sifarex M 10mg/120mg Chewable Tablet
By Sifarex M
Rx
10 Chewable Tablet in a Strip

Composition
Montelukast(10mg) + Fexofenadine(120mg)

Manufacturer - Siramed Pharmaceuticals (opc) Private Limited
Ground Floor, No. 44 & 45, 3rd Cross, 4th Main Road, Krishnappa Layout, GKW Layout, Peenya 2nd Stage, Bangalore - 560 058

Expires on or after
July, 2026

liver
Sifarex M 10mg/120mg Chewable Tablet is considered to be safe for individuals with liver disease, based on the limited data available. It is indicated that there may not be a requirement for dose adjustment of Sifarex M 10mg/120mg Chewable Tablet in these patients. However, it is essential to consult with your doctor before using this medication to ensure its safety and efficacy in your specific case.

kidney
Sifarex M 10mg/120mg Chewable Tablet needs caution in kidney disease patients. Dosage adjustment may be necessary. Consult your doctor. It can cause extra drowsiness in individuals with late-stage kidney disease.

alcohol
When taking Sifarex M 10mg/120mg Chewable Tablet, it is important to be cautious when consuming alcohol. Please consult your doctor regarding alcohol use.

driving
When taking Sifarex M 10mg/120mg Chewable Tablet, be cautious when driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Sifarex M 10mg/120mg Chewable Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a careful evaluation of risks and benefits before using this medication.

breastfeeding
Sifarex M 10mg/120mg Chewable Tablet is considered safe during breastfeeding based on limited data. It is unlikely to pose a significant risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | RESPIRATORY |
| Action Class | - |
₹159
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
